Presentations.ai AI Slide Generator Automates Investor Pitch Decks and Sales PPTs for 12 Million Users – The AI PowerPoint Maker Scales Professional Slide Generation With Branding, Design and Data ILC Dover Announces North America Expansion to Meet Growing Demand
Existing Juarez, Mexico Manufacturing Location Will Add Capacity and Advanced Capabilities for Life Sciences Customers…
Venture Capital Firm, Galaxy Interactive, Appoints Ryan You as Partner and Managing Director
You to Strengthen Gaming Relationships Globally NEW YORK–(BUSINESS WIRE)–Galaxy Interactive, a subsidiary of Galaxy Digital…
FashWire and GlossWire are Honored to Support Why Not You Foundation
SEATTLE–(BUSINESS WIRE)–#beauty–For the month of March, FashWire (App Store and Google Play) and GlossWire (App…
EchoNous Named to Fast Company’s Annual List of the World’s 50 Most Innovative Companies for 2022
Leading developer of AI-guided ultrasound technology joins the ranks of Canva, Microsoft, SpaceX, and more…
T-Mobile, America’s Leading 5G Network, to Offer the New iPhone SE and iPad Air with 5G on March 18
Get the new iPhone SE for $30 with eligible trade-in, available for pre-order on March…
Barnes Announces President and Chief Executive Officer Patrick J. Dempsey to Take a Temporary Leave of Absence
BRISTOL, Conn.–(BUSINESS WIRE)–Barnes Group Inc. (NYSE: B), a global provider of highly engineered products, differentiated…
Heliogen, Inc. Schedules Full-Year 2021 Financial Results and Conference Call
PASADENA, Calif.–(BUSINESS WIRE)–$HLGN #ArtificialIntelligence–Heliogen, Inc. (“Heliogen”) (NYSE: HLGN), a leading provider of AI-enabled concentrated solar…
OppFi Reports Fourth Quarter and Full-Year 2021 Financial Results
Net income for the fourth quarter of $17 million and $90 million for full-year 2021…
Smith Micro Reports Fourth Quarter and Fiscal Year 2021 Financial Results
PITTSBURGH–(BUSINESS WIRE)–$SMSI #commsuite–Smith Micro Software, Inc. (NASDAQ: SMSI) (“Smith Micro” or the “Company”) today reported…
CompoSecure, Inc. Announces Fourth Quarter and Full Year 2021 Financial Results
Fourth quarter net sales of $75.3 million, up 40.2% year-over-year Full year net sales of…
Startek Reports Fourth Quarter and Full Year 2021 Financial Results
– Revenue Growth for the Fourth Quarter and Full Year Driven by Continued Strength Across…
Limoneira Company Announces Fiscal First Quarter 2022 Financial Results
Achieves 3% Revenue Growth in the First Quarter Fiscal 2022 Compared to Prior Year, Driven…
BigBear.ai to Report Fourth Quarter and Full Year 2021 Results on March 17, 2022
COLUMBIA, Md.–(BUSINESS WIRE)–$BBAI–BigBear.ai (NYSE: BBAI), a leading provider of AI-powered analytics and cyber engineering solutions,…
Tilly’s, Inc. Finishes Record-Setting Fiscal 2021 with a Strong Fourth Quarter, Provides Fiscal 2022 First Quarter Outlook
IRVINE, Calif.–(BUSINESS WIRE)–Tilly’s, Inc. (NYSE: TLYS, the “Company”) today announced financial results for the fourth…
Willdan Group Reports Fourth Quarter Results and Provides 2022 Outlook
ANAHEIM, Calif.–(BUSINESS WIRE)–$WLDN–Willdan Group, Inc. (“Willdan”) (Nasdaq: WLDN), a provider of professional, technical and consulting…
LiveVox Announces Fourth Quarter and Full Year 2021 Financial Results
Q4 total revenue year-over-year growth of 13.3% to $31.9 million; full year total revenue growth…
KBRA Assigns Preliminary Ratings to Progress Residential 2022-SFR2
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns preliminary ratings to eight classes of Progress Residential 2022-SFR2 (Progress 2022-SFR2)…
Homology Medicines Announces Closing of Deal Leveraging its Internal Process Development and CMC Capabilities Through Newly Formed AAV Manufacturing Innovation Business with Oxford Biomedica
BEDFORD, Mass., March 10, 2022 (GLOBE NEWSWIRE) — Homology Medicines, Inc. (Nasdaq: FIXX), a genetic…
Oncternal Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2021 Financial Results
Reached consensus with the FDA on the design and major details of the global Phase…
Lumos Pharma Reports Full Year 2021 Financial Results and Announces Plan to Perform Interim Analyses of OraGrowtH Trials
Data from interim analyses of Phase 2 OraGrowtH210 Trial and PK/PD OraGrowtH212 Trial evaluating oral…